VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $291,000 | +51.6% | 12,500 | 0.0% | 0.16% | +43.9% |
| Q1 2018 | $192,000 | -26.2% | 12,500 | 0.0% | 0.11% | -40.0% |
| Q4 2017 | $260,000 | +45.3% | 12,500 | 0.0% | 0.19% | +35.7% |
| Q3 2017 | $179,000 | -15.6% | 12,500 | 0.0% | 0.14% | -15.7% |
| Q2 2017 | $212,000 | +53.6% | 12,500 | 0.0% | 0.17% | +46.9% |
| Q1 2017 | $138,000 | -24.2% | 12,500 | 0.0% | 0.11% | -28.5% |
| Q4 2016 | $182,000 | -1.1% | 12,500 | +66.7% | 0.16% | -4.2% |
| Q3 2016 | $184,000 | -24.0% | 7,500 | -37.5% | 0.16% | -25.3% |
| Q2 2016 | $242,000 | +130.5% | 12,000 | +200.0% | 0.22% | +125.5% |
| Q1 2016 | $105,000 | – | 4,000 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |